5 years after Pfizer buyout, SEC charges Medivation’s ex-dealmaking lead with insider trading

5 years after Pfizer buyout, SEC charges Medivation’s ex-dealmaking lead with insider trading
fkansteiner
Tue, 08/17/2021 – 11:22